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The complete amino acid sequences of two mouse glutamate receptor subunits (GluRl and GluR2) have been deduced by cloning and sequencing 
the cDNAs. Xenopus oocytes injected with mRNA derived from the GluRl cDNA exhibit current responses both to kainate and to quisqualate 
as well as to glutamate, whereas oocytes injected with mRNA derived from the GluR2 cDNA show little response. Injection of oocytes with both 
the mRNAs produces current responses larger than those induced by the GluRl-specific mRNA and the dose-response r lations indicate a positively 
cooperative interaction between the two subunits. These results suggest hat kainate and quisqualate can activate a common glutamate receptor 
subtype and that glutamate-gated ionic channels are hetero-oligomers of different subunits. 
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1. INTRODUCTION 
The glutamate receptor mediates excitatory transmis- 
sion at many synapses in the mammalian central ner- 
vous system and is involved in plastic and pathological 
processes [l-3]. Pharmacological and electrophysio- 
logical studies have suggested that there are at least five 
classes of glutamate receptor [l]. The receptors for N- 
methyl-D-aspartate (NMDA), quisqualate, kainate and 
L-2-amino-4-phosphonobutyrate (AP4) are subtypes 
of glutamate-gated ionic channels, whereas the re- 
ceptor for trans-1-amino-cyclopentyl-1,3-dicarboxylate 
(ACPD) is a G protein-coupled glutamate receptor. 
However, there has been no direct evidence for the 
presence of molecularly distinct glutamate receptor sub- 
types. Recently, Hollmann et al. [4] have reported the 
cloning, sequencing and expression of cDNA encoding 
a kainate subtype of the glutamate receptor from rat 
brain. The isolation and sequencing of cDNAs en- 
coding kainate binding proteins from chicken [5] and 
frog [6] have also been described. In the present inves- 
tigation, we have cloned and sequenced two cDNA 
species encoding glutamate receptor subunits from 
mouse cerebellum and have analyzed the functional 
properties of these subunits produced in Xenopus 
oocytes by expression of the cloned cDNAs. 
2. MATERIALS AND METHODS 
2.1. Cloning and sequencing of cDNAs 
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tamylglycine; GAMS, y-D-glutamylaminomethylsulphonate; GDEE, 
glutamate diethylester; APV, D-(-)-2-amino-5phosphonovaleric acid 
Total RNA was extracted [7] from ICR mouse cerebella, and po- 
ly(A)’ RNA was isolated by oligo(dT)-cellulose chromatography [8]. 
An oligo(dT)-primed cDNA library was constructed in phage XgtlO 
using poly(A)+ RNA as template. Double-stranded cDNA prepared 
using the cDNA synthesis ystem (Bethesda Research Laboratories) 
was blunted by T4 DNA polymerase, methylated by EcoRI 
methylase, ligated with an EcoRI linker and cleaved by EcoRI. Size- 
selected fragments longer than - 1 kb pair, prepared by elec- 
trophoresis on 1.5% agarose gel, were ligated with hgtl0. The screen- 
ing of the cDNA library was effected by hybridization at 42°C in the 
presence of 30% formamide with a rat kainate receptor cDNA probe 
prepared as follows. Polymerase chain reaction (PCR) amplification 
was carried out using cDNA synthesized from rat cerebral poly(A)+ 
RNA and synthetic oligodeoxyribonucleotides corresponding to 
nucleotide residues 1177-1201 and 2083-2107 of the rat GluR-Kl 
cDNA [4]. The 0.74-kb PstI fragment from the PCR-amplified pro- 
duct was used as a probe. 21 positive clones randomly chosen were 
classified into two groups by restriction mapping and partial sequence 
analysis. cDNA inserts from representative clones of each class, car- 
rying the entire protein-coding sequences of the glutamate receptor 
subunits GluRl and GluR2, were subcloned into pBluescript SK(-) 
(Stratagene) to yield the plasmids pKCR30 and pKCR24, respectively. 
Nested deletions were made [9] and DNA sequencing was carried out 
on both strands by the dideoxy chain termination method [ 10). Gaps 
and ambiguities were resolved by the use of appropriate synthetic 
primers. Oligodeoxyribonucleotides were prepared with an automatic 
DNA synthesizer (Applied Biosystems). 
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2.2. Expression of cDNAs 
The 3.2-kb EcoRI fragment from pKCR30 was cloned into the 
EcoRI site of pSP65 [l l] to yield the plasmid pSPGR1, which carried 
the GluRl cDNA in the same orientation as the SP6 promoter. The 
3.2-kb SuLWxrI fragment from pKCR24 was ligated with the 3.0-kb 
XbaI-SalI fragment from pSP64AX [12] to yield the plasmid 
pSPGR2. GluRl-specific and GluRZ-specific mRNAs were synthesiz- 
ed in vitro [ll] using HindID-cleaved pSPGR1 and XhoI-cleaved 
pSPGR2, respectively, as templates. Transcription was primed with 
the cap dinucleotide G(S’)ppp(S’)G (0.5 mM) [13]. Xenopus laevis 
oocytes were injected with the GluRl-specific and/or the GluR2- 
specific mRNA; the concentration of the respective mRNAs was 0.1 
or 0.2rg/pl and the average volume injected was - 50 nl per oocyte. 
The injected oocytes were incubated at 20°C for 3 days in modified 
Barth’s medium [14] containing gentamycin (0.1 mg/ml). The 
follicular cell layer was removed [15] and whole-cell currents were 
recorded at - 70 mV membrane potential and - 19°C with a conven- 
tional two-micropipette voltage clamp; the two pipettes were filled 
with 3 M KCl. The chamber was continuously perfused with normal 
frog Ringer’s solution composed of 115 mM NaCl, 2.5 mM KCI, 1.8 
mM CaCl2 and 10 mM Hepes-NaOH (pH 7.2). Glutamate receptor 
agonists were bath-applied for - 15 s; the NMDA solution applied 
contained 6,4M glycine. 
3. RESULTS AND DISCUSSION 
A cDNA library derived from mouse cerebellar po- 
ly(A)+ RNA was constructed with the bacteriophage 
vector AgtlO and was screened by hybridization with a 
DNA fragment comprising part of the rat kainate 
receptor GluR-Kl cDNA [4]. Two classes of cDNA 
clones were isolated and sequence analysis of represen- 
tative clones of each class, GluRl and GluR2, revealed 
open reading frames that encode sequences of 907 and 
883 amino acids, respectively (Figs. 1 and 2). The 
translational initiation site was assigned to the first 
ATG triplet that appears downstream of a nonsense 
codon found in-frame. Both the proteins contain a 
putative amino-terminal signal peptide, whose cleavage 
site was predicted by the method of von Heijne [16]. 
The proposed mature GluRl and GluR2 proteins are 
composed of 889 and 862 amino acid residues with 
calculated M, of 99,645 and 96,207, respectively. Fig. 3 
shows the alignment of the deduced amino acid se- 
quences of the GluRl and GluR2 proteins, which ex- 
hibit 71% sequence identity with each other. As com- 
pared with the rat kainate receptor GluR-Kl [4] and the 
chick [5] and frog [6] kainate binding proteins, the 
GluRl protein shows 99%, 37% and 38% sequence 
identity, respectively, and the GluR2 protein 7 1%) 39% 
and 39% sequence identity, respectively. 
Analysis of the deduced amino acid sequences for 
local hydropathicity [ 181 suggests the presence of four 
putative transmembrane segments (Ml-M4) in the 
GluRl and GluR2 proteins. The hydrophobicity of 
segments Ml, M3 and M4 is high enough to allow 
unambiguous assignment. Comparison of the hydro- 
pathicity profiles of GluRl and GluR2 with those of the 
rat kainate receptor [4], the chick and frog kainate bin- 
ding proteins [5,6] and the subunits of other neuro- 
transmitter-gated ionic channels [19-211 leads to the 
74 
assignment of segment M2, although its hydrophobicity 
is not very high. The structural characteristics observed 
suggest that the GluRl and GluR2 proteins have the 
same transmembrane topology, with the amino- 
terminal region assigned to the extracellular side of the 
membrane, as proposed for the rat kainate receptor [4], 
the kainate binding proteins [5,6] and the subunits of 
neurotransmitter-gated ionic channels [19-211; note 
that a region different from segment M2 was also pro- 
posed as a putative transmembrane segment of the rat 
kainate receptor [4]. This model is consistent with all 
the potential N-glycosylation sites [22] found in GluRl 
and GluR2 (Fig. 3, marked with asterisks) being located 
on the extracellular side of the membrane. The region 
preceding segment Ml of GluRl and GluR2 contains 
clusters of amino acid residues conserved in the rat 
kainate receptor and the kainate binding proteins 
(Fig. 3, underlined). These sites might be involved in 
ligand binding. Segment M2 of GluRl and GluR2 is 
surrounded by negatively charged amino acid residues 
(residues 562, 566 and 586 of GluRl and residues 566, 
570 and 590 of GluR2). Interestingly, these residues are 
located at positions nearly equivalent to those of the 
three rings of negatively charged and glutamine residues 
that surround segment M2 of the nicotinic acetylcholine 
receptor subunits [23]. The three anionic rings, of 
which two are located near the cytoplasmic and ex- 
tracellular mouths of the channel and the other is 
located between the two, forming a narrow channel 
constriction, have been identified as major deter- 
minants of the rate of ion transport through the 
acetylcholine receptor channel [23]. 
mRNAs specific for the GluRl and GluR2 proteins 
were synthesized by transcription in vitro of the cloned 
cDNAs and were injected singly or together into 
Xenopus oocytes. After incubation for 3 days, the in- 
jected oocytes were tested for current responses to 
glutamate receptor agonists. Almost all oocytes injected 
with the GluRl-specific mRNA responded to 30/cM L- 
glutamate (Fig. 4A and Table I). This indicates that the 
GluRl protein is a glutamate receptor subunit. As ex- 
pected from the 99% sequence identity observed be- 
tween GluRl and the rat kainate receptor GluR-Kl [4], 
all injected oocytes responded to 100,uM kainate. Unex- 
pectedly, however, 1 PM quisqualate also evoked a clear 
response in almost all oocytes. Three out of the 30 
oocytes tested exhibited a small response to 100 PM L- 
aspartate. No detectable response was observed with 
100 PM NMDA. None of 30 noninjected control 
oocytes responded to these glutamate receptor agonists. 
The responsiveness of GluRl both to kainate and to 
quisqualate is in contrast with the reported selectivity of 
the rat kainate receptor GluR-Kl for kainate [4]. 
Kainate evoked larger current responses than quis- 
qualate, but quisqualate showed much higher apparent 
affinity than kainate as indicated by the effector con- 
centrations required for half-maximal response (EC5o). 
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Fig. 1. Nucleotide sequence of cloned cDNA encoding the mouse GluRl protein and the deduced amino acid sequence. Nucleotide residues are 
numbered in the 5 ’ - to 3 ‘-direction, beginning with the first residue of the codon specifying the amino-terminal residue of the mature subunit and 
the preceding residues are indicated by negative numbers. Amino acid residues are numbered beginning with the amino-terminal residue of the 
mature subunit and the preceding residues are indicated by negative numbers. Numbers of the nucleotide and ammo acid residues at the right-hand 
end of the individual lines are given. In the cDNA sequence, nucleotide 2815 is followed by a stretch of 11 dA residues, which may not represent 
the poly(A) tail because no conventional polyadenylation signal is found. 
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ctGAcAccccAtATcGAcAAtTTGGAGGTAGCCAACAGTTTCGCAGTCACCAATGCTTlCTGCTCCCAGttTTcAAGAGGCGtcTAlGcGAtTTtTGGGTTTTACGAC 216 
LeuTh~pro~~lsIIcAsPAsnLeuGluValAlaAsnSerPheAlaValThrAsnAlaPheCysSerGlnPheSerA~gGlyVslTy~Al~IlePh~GlyPheTyrAsp 72 
AAGAAG~~TG~AAATACCATCACATCATTCTGTGGGACACTGCATG~ATCCT~CATCACACCAAGCTTCCCAACAGATGGCA~GCATCCATTTGTCATCCAGATGCGA 324 
LysLysSe~Va~AsnThrIlethrSerPheCysGlyThrLeuHisVslSerPheIleThrPraSerPheProThrAspGlyth~H~sProPheValIleGlnMetArg 108 
CCTGACC~CAAAGGAGCACTCCTTAGCTTGATTGAGTACTACCAATGGGATAAGTTCGCATACCTC~ATGACAG~GACAGAGG~TTATCAACACTGCAAGCTGTGCTG 432 
ProAspLeuLysGlyAldLeuLeuSerLeulleGluTyrTyrGlnTrpAspLysPheAlsTyrLeuTyrAspSerAspArgGlyLe~SerThrLe~GlnAlsVslLe~ 144 
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GCAAATCtGGGATTTACTGATGGAGACCTGCtGAAAATTCAGTTTGGAGGAGCAAATGTCTCtGGATTTCAGATtGTAGtCTACGACGACTCCCTGGCGlCTAAAlTT 756 
AlaAsnLeuGlyPheThrAspGlyAspLeuLeuLysIleGlnPheGlyGlyAlsAsnValSerGlyPheGlnI~aVslV~lTyrAspAspSerLe~AlaSerLysPhe 252 
ATAGAAAGATGGTCAACACTCGAAGGAAAAGAATACCCTGGAGCACACACAGCGACAATTAAGTATACTTCGGCCCTGACTTATGATGCTGTCCAAGTGATGACTGAA 864 
IleGluArgTrpSerThrLeuGluGlyLysGluTyrProGIyAlaHisThrAlaThrIleLysTyrThrSerAl~LeuThrTyrAspAlaVslGlnVslMetThrGlu 288 
GCATTCCGCAATCTTCGGAAGCAGAGGATTGAAATCTCCAGGAGAGGAAATGCAGGAGATTGTTTGGCCAACCCAGCTGTGCCTTGGGGACAAGGCGTGGAAATAGAA 972 
AlaPheArgAsnLeuArgLysGlnArgIleGluIleSerArgArgGlyAsnAlaGlyAspCysLeuAlaAsnProAlsVslProTrpGlyGlnGlyValGluIleGlu 324 
AGGGCCCTCAAGCAGGTTCAAGTTGAAGGTCTCTCTGGAAATATAAAATTTGACCAGAACGGAAAACGAATAAACTACACAATTAACATCATGGAGCTCAAAACAAAT 1080 
ArgAlaLeuLysGlnValG1nValGluGlyLeuSerGlyAsnIleLysPheAspGlnAsnGlyLysArgIleAsnTyrThrIleAsnIle~etGluLeuLysThrAsn 360 
GGACCCCGGAAGATTGGGTACTGGAGTGAAGTGGATAAAATGGTTGTCACCCTAACCGAGCTCCCCTCTGGAAATGACACATCTGGGCTTGAAAACAAAACTGTGGTT 
GlyProArgLysIleGlyTyrTrpSerGluValAspLys~etV~lV~lThrLeuThrGluLeuProSerGlyAsnAspThrSerGlyLeuGluAsnLyslhrValVsl 
1188 
396 
GTCACCACAATAtTGGAATCTCCATAtGttAtGATGAAGAAAAATCATGAAATGCTtGAAGGGAATGAGCGtlATGAGGGCTACTGTGTTGACtTAGCtGCAGAAATT lL96 
ValThrThrIleLeuGluSerProTyrVslHet~etLysLysAsnHisGlu~etLeuGluGlyAsnGluArgTyrGluGlyTyrCysV~lAspLeuAlsA~aGluIle 432 
GCCAAACATTGTGGATTCAAGTACAAGCTGACTATTGTTGGGGATGGCAAGTATGGGGCCAGGGATGCAGACACCAAAATTTGGAATGGTATGGTTGGAGAACTTGTA 
AlaLysH~sCysGlyPheLysTyrLysLeuThrIleValGlyAspGlyLysTyrGlyAlaArgAspAlsAspThrLysIleTrpAsnGlyMetV~lGlyGluLeuVsl 
TATGGGAAAGCTGATATtGCCATTGCTCCATtAACTATCACTCTCGtGAGAGAAGAGGtGATTGACTTcTCGAAGCCATTCATGAGCCTTGGAATCTCTAtCATGATC 
TyrGlyLysAlaAspIleAlalleAlsProLeuThrIleThrLeuV~lArgGluGluValIleAspPheSerLysProPhe~etSerLeuGlyIleSerIleHetIle 
AAGAAGCCTCAGAAGTCCAAACCAGGAGTGTTTTCCTTTCT?GATCCTTTAGCCTATGAGATCTGGATGTGCAtTGTGTTTGCCTACAtTGGGGTCAGTGTAGTTTTA 
LysLysProGlnLysSerLysProGlyValPheSerPheLe~AspProLe~Al~TyrGluIleTrpMetCysIleValPheAlaTyrIleGlyV~lSerVslValLeu 
TTCCTGGTCAGCAGATTTAGCCCCTACGAGTGGCACACTGAGGAATTTGAAGATGGAAGAGAAACACAAAGTAGTGAATCAACTAATGAATTTGGGATTTTTAATAGT 
PheLe~ValSerAr9PheSerProTyrGluTrpHtsThrGl~GluPheGl~AspGlyArgGluThrGlnSerSerGluSerthrAsnGluPheGlyIlepheAsnSer 
CTC GGTTTTCCTTGGGTGCCTTTATGCGGCAAGGATGCGATATTTCGCCAAGATCTCTCTCTGGGCGCATTGTTGGAGGTGTGTGGTGGTTCTTTACCCTCATCATC 
Leu rpPheSerLe~GlyAlaPheWetArgGlnGlyCysAspIleSerProArgSerLeuSerGlyArgIleValG~yGlyVslTrpTrpPhePheThrLeuIleIle T 
ATCTCCTCCTACACGGCTAACTTAGCTGCCTTCCTGACTGTAGAGAGGATGGTGTCGCCCATCGAAAGTGCTGAGGATCTGTCTAAGCAAACAGAAATTGCTTATGGA 
.IleSerSerTyrThrAlaAsnLeuAlaAlaPheLeuThrValGl~ArgMetValSerProIleGluSerAlsGluAspLeuSerLysGlnthrGluIleAlstyrGly 
ACATTAGACTCTGGCTCCACTAAAGAGTTTTTCAGGAGATCTAAAATTGCAGTGTTTGATAAAATGTGGACTTATATGAGGAGTGCAGAGCCCTCTGTGTTTGTGAGG 
ThrLe~AspSerGlyS~rThrLysGl~PhePheArgAr9SerLysIleAlaVslPheAspLysMetTrpThrTyrHetArgSerAlaGluPraSerValPheVs~Arg 
ActAcGGCAGAAGGAGTAGCCAGAGTCAGGAAATCCAAAGGGAAGTATGCCTACTTGCTGGAGTCCAcAATGAATGAGTAcATCGAGCAGAGGAAGcCTTGcGAcAcC 
ThrThrAlsGl~GlyValAlaArgVslArgLysSerLysGlyLysTyrAl~TyrLeuLeuGluSerThrMetAsnGluty~IleGluGlnAr9LysprocysAspThr 
AtGAAAGtGGGcGGcAACcTGGATTccAAAGGCTAcGGCATCGCCACACCtAAAGGATCCTCATTAGGAAAtGCGGTTAAcCTCGCAGTACTAAAAcTGAATGAACAA 
~c~LysVslGlyGlyAsnL~uArpS~rLysGlyTyrGlyIleAlsThrProLysGlySerSerLeuGlyAsnAlaValAsnLeuAlaValLeuLysLeuAsnG~uGln 
GGcctGtTGGAcAAATTGAAAAAcAAATGGTGGTACGACAAAGGAGAGTGCGGCAGCGGGGGAGGTGATTccAAGGAAAAGAcCAGTGcCctcAGTctGAGcAAcGtT 
GlyLe~Le~AspLysLeuLysAsnLysTrpTrpTyrAspLysGlyGluCysGlySerGlyGlyGlyAspSerLysGluLysthrSerAlaLeuSerLeuSe~AS~V~~ 
GcTGGAGTATTctAcATCctTGtCGGGGGCCTTGGTTTGGCAATGCtGGTGGCtTtGAtTGAGTTCTGTTACAAGTCAAGGGCCGAGGCGAAACGAATGAAGGtGGcA 
AlsGlyvalPhctyrIleLeuVIlClyGlyGlyLeuGlyLe~AlaMetLeuVslAlaLeuIleG~PheCystyrLysSerArgAlsGluAlaLysA~g~etLysVs~A~s 
AAGAAtGcAcAGAATAtTAAcccAtctTcctCGCAGAATTcCCAGAATTTTGCAACTTATAAGGAAGGTtACAACGTATATGGCATCGAGAGtGTTAAAATtTAGGGG 
LysAsnAlaGlnAsnIleArnProScrSerSerGlnAsnSerGlnAsnPh~Al~ThrTyrLysGtuG~yTyrAsnV~lty~GlyI~eG~uSe~Va~LysI~e 
ATGA~~TTGAG~G~TGCCACGAGGAACAAGGCAAGG~TGTCAATTACAGGAAGTACTGGAGAAAATGGACGTGTTATGACTCCAGAATT~~C~AAAGCAG~G~ATG~~ 
G~~~~TTA~GTGAGT~CTGG~A~GGGAATGAATGTCAGTGTGACTGATCTCTCGTGATTGATAGGAACCTTCTGAGTGCCTTACACAATGG~~~C~T~G~GTG~T~AT 
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Fig. 2. Nucleotide sequence of cloned cDNA encoding the mouse GluR2 protein and the deduced amino acid sequence. For numbering of 
nucleotide and amino acid residues, see the legend to Fig. 1. 
The ECsc values obtained from the dose-response The effects of various glutamate receptor antagonists 
curves were 9.2 pM, 36 ,uM and 0.15 PM for L- were examined at a concentration of 1 mM (Table II). 
glutamate, kainate and quisqualate, respectively The response of 1OOpM kainate in oocytes injected with 
(Fig. 4C). The Hill coefficients calculated from these the GluRl-specific mRNA was suppressed by 
curves were 0.74, 1.1 and 0.83 for L-glutamate, kainate kynurenate, a glutamate receptor antagonist with broad 
and quisqualate, respectively. specificity, and was inhibited to some extent by r-D- 
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Fig. 3. Alignment of the deduced amino acid sequences of the GluRl and GluR2 proteins. Sequence comparison was performed using GENETYX 
software (SDC Corp. Inc.). Numbers of the amino acid residues at the right-hand end of the individual lines are given. Sets of identical amino 
acid residues in the homologous region (residues - 15 to 822 of GluRl and residues - 15 to 826 of GluR2) are enclosed by solid lines, and sets 
of conservative residues [17] by broken lines. The non-homologous regions are indicated by dashed lines beneath the sequences. The asparagine 
residues as potential N-glycosylation sites are marked with asterisks. The putative transmembrane segments (Ml-M4) are indicated. Clusters of 
amino acid residues conserved among GluRl, GluR2, rat GluR-Kl [4] and the chick [S] and frog [6] kainate binding proteins are underlined. 
glutamylglycine (y-DGG) and y-D-glutamylamino- 100 PM NMDA (Table I). One of the 30 oocytes tested 
methylsulphonate (GAMS), reported to act preferen- showed a marginal response to 100 ,uM kainate (Table 
tially on kainate and NMDA receptors 1241 and on I). Similar results were obtained when the mRNA was 
kainate and quisqualate receptors [25], respectively. injected in a 5-fold higher concentration. 
Glutamate diethylester (GDEE), thought to be selective Oocytes injected with both the GluRl-specific and 
for quisqualate receptors [26], showed essentially no in- the GluR2-specific mRNA displayed larger current 
hibitory effect, but exhibited weak agonist activity. The responses to 30 PM L-glutamate, 100 ,uM kainate and 1 
NMDA receptor antagonist D-(-)-2-amino-5-phos- ,uM quisqualate than those injected with the GluRl- 
phonovaleric acid (APV) slightly inhibited the’response specific mRNA alone (Fig. 4B and Table I); note the 
to kainate. difference in vertical scale between Fig. 4A and B. The 
Oocytes injected with the GluR2-specific mRNA ex- additive effect was most prominent for the response to 
hibited no detectable response to 30 ,uM L-glutamate, 1 1OOpM kainate. Thus, the glutamate receptor produced 
PM and 100 PM quisqualate, 100 ,uM L-aspartate and in oocytes by injection of both the GluRl-specific and 
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Fig. 4. Functional properties of the GluRl and GluR2 proteins expressed in Xenopus oocytes. A and B, Whole-cell currents activated by bath ap- 
plication of 30rM L-glutamate (Glu), 100,uM kainate (Kain) and 1 ,uM quisqualate (Quis) in an oocyte injected with the GluRl-specific mRNA 
(0.1 pg/+l) alone (A) or with both the GluRl-specific and the GluR2-specific mRNA (0.1 pg/J each) (B). Membrane potential, - 70 mV. Inward 
current is downward. The duration of agonist application is indicated by bars without taking into account the dead-space time in the perfusion 
system (- 1 s). C, Dose-response curves for inward currents activated by L-glutamate (circles), kainate (triangles) or quisqualate (squares) in 
oocytes injected with the GluRl-specific mRNA (0.2 Fg/pl) alone (open symbols) or with both the GluRl-specific and the GluRZ-specific mRNA 
(0.1 fig/PI each) (closed symbols). Each point represents the mean + SD of measurements on 4-l 1 oocytes at - 70 mV membrane potential. The 
theoretical curves have been drawn according to the equation Z= Z,., /[l + (ECXJA)“], where Z represents the current response, I,,,, the maximum 
response, A the concentration of agonist, and n the Hill coefficient. The maximum current responses were 14-48 nA (0), 16-70 nA (A), 6-22 
nA (0), 7-36 nA (o), 112-313 nA (A) and 5-19 nA (D). 
Table I 
Whole-cell currents activated by glutamate receptor agonists in Xenopus oocytes injected with either or both of the 
GluRl-specific and the GluRZ-specific mRNA 
mRNA injected Whole-cell currents activated (nA) 
30 ,uM 100,uM 1rM 100,uM 1OO~M 
L-glutamate kainate quisqualate L-aspartate NMDA 
GluRl 11 * 15 29 + 23 9 f 13 2* 1 
(29/30) (30/30) (28/30) (3/30) (07 fb) 
GluR2 
( &YO) ( 1)30) ( CYO) (%) (0::) 
GluR 1, GluR2 29 + 26 267 + 191 15 It 14 
(30/30) (30/30) (30130) (2;O) 
Oocytes were injected with the GluRl-specific mRNA (0.1 pg/pl) or the GluRZ-specific mRNA (0.1 /g/PI) or both 
(0.1 /g/p1 each). Inward currents activated by each agonist were recorded at - 70 mV membrane potential. Data 
are given as mean f SD when indicated; the means have been calculated only for the responsive oocytes. Numbers 
in parentheses indicate the number of responsive oocytes relative to the number of oocytes tested. Our detectable 
limit was - 1 nA. ND, not detectable 
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TABLE II 
Sensitivities to antagonists of the GluRl protein expressed alone or 
together with the GluR2 protein 
Antagonist added 
(1 mM) 
Response to 1OOrM kainate (&) 
GluRl GluRl, GluR2 
None 100 100 
Kynurenate 25 f 5 (4) 10 + 0.7 (3) 
r-DGG 55 f 1 (4) 42 f 3 (4) 
GAMS 54 f 2 (4) 39 f 2 (3) 
GDEE 98 rt 2 (5) 97 f 3 (4) 
APV 82 * 2 (4) 73 f 0.9 (4) 
Oocytes were injected with the GluRl-specific mRNA (0.2 pg/Fl) 
alone or with both the GluRl-specific and the GluRZ-specific mRNA 
(0.1 pg/pl each). Inward currents activated by 1OOpM kainate in the 
presence and absence of 1 mM antagonist were recorded at - 70 mV 
membrane potential. Data are given as means f SD; numbers in 
parentheses indicate the number of oocytes tested. The current 
responses to 100 pM kainate were 5-54 nA for the oocytes injected 
with the GluRl-specific mRNA alone and 18-151 nA for the oocytes 
injected with both the GluRl-specific and the GluR2-specific mRNA. 
No current response was detected when atagonist alone was applied, 
except that GDEE evoked a small response in the oocytes injected 
with the GluRl-specific mRNA alone (6 f 4% of the response to 100 
pM kainate, n=5) 
the GluRZ-specific mRNA is more selective for kainate 
than that produced by injection of the GluRI-specific 
mRNA alone. The EC50 values were 5.7,~M, 91 PM and 
0.12 PM for L-glutamate, kainate and quisqualate, 
respectively (Fig. 4C). The values for L-glutamate and 
quisqualate are similar to those obtained for GluRl ex- 
pressed alone, whereas the value for kainate is 
somewhat larger. The Hill coefficients calculated were 
2.0, 1.5 and 2.4 for L-glutamate, kainate and quis- 
qualate, respectively. These values, especially those for 
L-glutamate and quisqualate, are larger than those ob- 
tained for GluRl expressed alone (close to unity), in- 
dicating a positively cooperative interaction between 
the GluRl and GluR2 proteins. The increase in channel 
activity and cooperativity, together with the amino acid 
sequence similarity, suggests that GluR2 is also a 
glutamate receptor subunit. The response to 100 PM 
kainate in oocytes injected with both the GluRl-specific 
and the GluR2-specific mRNA was inhibited by 
kynurenate, y-DGG, GAMS and APV (Table II). The 
extents of inhibition were somewhat larger than those 
observed for GluRl expressed alone. GDEE exhibited 
essentially no effect. 
The present investigation demonstrates a molecular 
species of glutamate receptor which is responsive both 
to kainate and to quisqualate. This supports the view 
that kainate and quisqualate may activate a common 
receptor subtype [27-291. Our results also show that co- 
expression in Xenopus oocytes of the two glutamate 
receptor subunits GluRl and GluR2 produces higher 
channel activity and cooperativity, as compared with 
the GluRl subunit expressed alone. This suggests that 
glutamate-gated ionic channels, like other neuro- 
transmitter-gated ionic channels, are hetero-oligomers 
of different subunits, although the combination of 
GluRl and GluR2 may not necessarily represent a 
native receptor. 
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